{"id":"W2085214163","doi":"10.1016/s0960-9776(09)70271-1","title":"Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancer","year":2009,"lang":"en","type":"review","venue":"The Breast","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Bevacizumab; Sunitinib; Oncology; Sorafenib; Internal medicine; Breast cancer; Drug; Antiangiogenic therapy; Metastatic breast cancer; Cancer; Taxane; Chemotherapy; Pharmacology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001409379,0.0007811286,0.001937629,0.001553048,0.000387044,0.00129039,0.001228434,0.002381018,0.003454354],"category_scores_gemma":[0.001686854,0.0002955733,0.0004876944,0.001985124,0.0007423381,0.002005294,0.00063528,0.003260741,0.001763445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001092658,"about_ca_system_score_gemma":0.001628719,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001804449,"about_ca_topic_score_gemma":0.003881048,"domain_scores_codex":[0.9996753,0.00006344106,0.00004481905,0.00004653596,0.0001365284,0.00003334118],"domain_scores_gemma":[0.9990036,0.000533346,0.0001063326,0.00001980946,0.0002698755,0.00006712347],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001499132,0.00009653737,0.0001423809,0.00835235,0.00007123679,0.0002657165,0.00003838585,0.0004160144,0.00169318,0.004780487,0.05387025,0.9301236],"study_design_scores_gemma":[0.0000565329,0.0001201905,0.0007519968,0.002361661,0.0001444115,0.001421527,0.00006526829,0.0001674665,0.0005976083,0.002692193,0.991599,0.00002215622],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006083006,0.9983588,0.00009958102,0.0007488136,0.0002491919,0.000002306444,0.000007581322,0.000004207518,0.0004688028],"genre_scores_gemma":[0.0004451889,0.9983137,0.0001842501,0.0004170231,0.0002983462,0.00000341826,0.00001370318,9.985475e-7,0.0003233333],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003454354,"threshold_uncertainty_score":0.01155597,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0270583760729518,"score_gpt":0.3530794942608489,"score_spread":0.3260211181878971,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}